Oura has closed a $200 million round, bringing its value to $5.2 billion

Smart ring maker Oura announced Thursday that it has closed a $200 million Series D funding round, valuing the company at $5.2 billion. The tour includes participation from Fidelity Management and glucose device maker Dexcom.

Oura says the new capital will allow it to expand its product offerings and focus on products, science, artificial intelligence and more. will allow further investment in the fields. The funding will also allow Oura to explore additional acquisitions, the company said.

The news is coming A month after announcing the collaboration with Oura Deckhom enabling the two companies’ devices and software to be used together. The partnership means Oura rings will help users track their blood sugar and the two companies will co-market and cross-sell each other’s products. Oura said at the time that Dexcom would invest $75 million in a Series D round.

“As we continue to accelerate momentum and growth, we are strengthened by the additional support of these investors,” Oura CEO Tom Hale said in a press release. “We have made significant progress in advancing our mission to make health an everyday experience, and we will use this funding to unlock new opportunities with AI development at the heart of our strategy. We know Oura has the potential to change lives at scale, and we’re excited to continue to lead the market in innovation as we look for opportunities that go beyond the ring.

Oura has sold more than 2.5 million rings, and the company’s member base and revenue have more than doubled over the past year.

In 2024, the company expanded its retail sales by bringing its products Amazon and Target. It has also partnered with the Naval Health Research Center, the Air Force and the Defense Innovation Division to put its Smart Rings on the fingers of servicemen.

In October Oura gained Spartan Science, A Bay Area-based health tracking startup. In September Oura has acquired Datathe Helsinki-based startup behind the metabolic health product of the same name.